STK17A Polyklonaler Antikörper

• Featured Product
• KD/KO Validated

STK17A Polyklonal Antikörper für IHC, WB,ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC,ELISA

Konjugation

Unkonjugiert

Publikationen

1

Kat-Nr. : 14433-1-AP

Synonyme

DRAK1, serine/threonine kinase 17a, STK17A

---

Galerie der Validierungsdaten

• 

  WB analysis of BxPC-3 using 14433-1-AP

  BxPC-3 cells were subjected to SDS PAGE followed by western blot with 14433-1-AP (STK17A antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of human skeletal muscle using 14433-1-AP

  human skeletal muscle tissue were subjected to SDS PAGE followed by western blot with 14433-1-AP (STK17A antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of mouse skeletal muscle using 14433-1-AP

  mouse skeletal muscle tissue were subjected to SDS PAGE followed by western blot with 14433-1-AP (STK17A antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of NIH/3T3 using 14433-1-AP

  NIH/3T3 cells were subjected to SDS PAGE followed by western blot with 14433-1-AP (STK17A antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of BxPC-3 using 14433-1-AP

  BxPC-3 cells were subjected to SDS PAGE followed by western blot with 14433-1-AP (STK17A antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human heart using 14433-1-AP

  Immunohistochemical analysis of paraffin-embedded human heart using 14433-1-AP (STK17A antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human heart using 14433-1-AP

  Immunohistochemical analysis of paraffin-embedded human heart using 14433-1-AP (STK17A antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human placenta using 14433-1-AP

  Immunohistochemical analysis of paraffin-embedded human placenta using 14433-1-AP (STK17A antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human placenta using 14433-1-AP

  Immunohistochemical analysis of paraffin-embedded human placenta using 14433-1-AP (STK17A antibody) at dilution of 1:50 (under 40x lens).

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: BxPC-3-Zellen, humanes Skelettmuskelgewebe, Maus-Skelettmuskelgewebe, NIH/3T3-Zellen
• Erfolgreiche Detektion in IHC: humanes Herzgewebe, humanes Plazenta-Gewebe; Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:500-1:3000
• Immunhistochemie (IHC): IHC : 1:20-1:200

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• KD/KO: See 1 publications below
• WB: See 1 publications below

Produktinformation

14433-1-AP bindet in WB, IHC,ELISA STK17A und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• In Publikationen genannte Reaktivität: human
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: STK17A fusion protein Ag5811
• Vollständiger Name: serine/threonine kinase 17a
• Berechnetes Molekulargewicht: 47 kDa
• Beobachtetes Molekulargewicht: 47-53 kDa
• GenBank-Zugangsnummer: BC047696
• Gene symbol: STK17A
• Gene ID (NCBI): 9263
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Publikationen

Species	Application	Title
human	WB	Mol Med Rep; Prognostic and predictive roles of microRNA‑411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer.; Authors - Wei Wei ; KD Validated